PharmaSGP Holding SE (ETR: PSG)

PharmaSGP Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	37.77	40.77	32.64	20.82	8	88.48
Trading Asset Securities	-	-	1.24	-	-	-
Cash & Short-Term Investments	37.77	40.77	33.88	20.82	8	88.48
Cash Growth	-0.74%	20.32%	62.71%	160.27%	-90.96%	14.89%
Accounts Receivable	15.97	8.92	7.76	6.49	9.41	9.19
Other Receivables	-	0.49	0.34	0.74	1.68	2.23
Receivables	15.97	9.42	8.1	7.23	11.09	11.42
Inventory	10.96	10.12	7	4.19	3.04	2.1
Other Current Assets	2.76	2.52	2.52	0.29	0.24	0.1
Total Current Assets	67.45	62.82	51.51	32.53	22.37	102.09
Property, Plant & Equipment	0.92	1.18	1.57	0.54	0.75	0.25
Long-Term Investments	0.67	1.25	2.08	-	-	-
Other Intangible Assets	60.48	66.06	73.94	82.19	1.77	1.39
Other Long-Term Assets	-	-	-	-	0.06	-
Total Assets	129.52	131.3	129.11	115.26	24.94	103.74
Accounts Payable	13.05	9.92	8.79	4.52	9.79	0.81
Accrued Expenses	-	0.21	0.37	0.44	0.07	1.41
Short-Term Debt	-	-	-	85	-	-
Current Portion of Long-Term Debt	7.72	7.71	7.66	-	-	-
Current Portion of Leases	0.48	0.44	0.4	0.19	0.24	0.25
Current Income Taxes Payable	3.09	1.42	-	0.19	0.2	3.92
Other Current Liabilities	5.44	4.9	5.53	2.39	2.74	1.55
Total Current Liabilities	29.78	24.59	22.74	92.73	13.04	7.94
Long-Term Debt	61.59	65.37	73.06	-	-	-
Long-Term Leases	0.13	0.45	0.82	0	0.15	-
Long-Term Deferred Tax Liabilities	0.76	0.79	1.23	0.27	0.22	0.22
Other Long-Term Liabilities	0.31	0.34	0.17	0.06	0.04	-
Total Liabilities	92.57	91.55	98.01	93.06	13.44	8.16
Common Stock	12	12	12	12	12	95.58
Retained Earnings	-13.1	-10.85	-21.37	-27.92	-38.61	-
Treasury Stock	-	-0.29	-	-	-	-
Comprehensive Income & Other	38.05	38.89	40.47	38.12	38.12	-
Shareholders' Equity	36.95	39.75	31.1	22.2	11.51	95.58
Total Liabilities & Equity	129.52	131.3	129.11	115.26	24.94	103.74
Total Debt	69.92	73.98	81.94	85.19	0.38	0.25
Net Cash (Debt)	-32.15	-33.21	-48.06	-64.37	7.62	88.22
Net Cash Growth	-	-	-	-	-91.37%	15.32%
Net Cash Per Share	-2.68	-2.77	-4.00	-5.36	0.63	7.35
Filing Date Shares Outstanding	11.92	11.99	12	12	12	12
Total Common Shares Outstanding	11.92	11.99	12	12	12	12
Working Capital	37.67	38.22	28.77	-60.2	9.33	94.15
Book Value Per Share	3.10	3.32	2.59	1.85	0.96	7.96
Tangible Book Value	-23.53	-26.3	-42.85	-59.99	9.74	94.19
Tangible Book Value Per Share	-1.97	-2.19	-3.57	-5.00	0.81	7.85

Source: S&P Capital IQ. Standard template. Financial Sources.